Journal
CELL METABOLISM
Volume 4, Issue 6, Pages 453-464Publisher
CELL PRESS
DOI: 10.1016/j.cmet.2006.11.003
Keywords
-
Categories
Funding
- NIDDK NIH HHS [U24 DK059635, R01 DK049569, R01 DK040936, DK49569, DK61562, R01 DK061562] Funding Source: Medline
Ask authors/readers for more resources
PGC-1 beta is a transcriptional coactivator that potently stimulates mitochondrial biogenesis and respiration of cells. Here, we have generated mice lacking exons 3 to 4 of the Pgc-1 beta gene (Pgc-1 beta(E3,4-/E3,4-) mice). These mice express a mutant protein that has reduced coactivation activity on a subset of transcription factors, including ERR alpha, a major target of PGC-1 beta in the induction of mitochondrial gene expression. The mutant mice have reduced expression of OXPHOS genes and mitochondrial dysfunction in liver and skeletal muscle as well as elevated liver triglycerides. Euglycemic-hyperinsulinemic clamp and insulin signaling studies show that PGC-1 beta mutant mice have normal skeletal muscle response to insulin but have hepatic insulin resistance. These results demonstrate that PGC-1 beta is required for normal expression of OXPHOS genes and mitochondrial function in liver and skeletal muscle. Importantly, these abnormalities do not cause insulin resistance in skeletal muscle but cause substantially reduced insulin action in the liver.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available